These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
446 related items for PubMed ID: 12866567
1. Radical surgery does not recover immunodeficiency associated with gastric cancer. Romano F, Caprotti R, Bravo AF, Conti M, Colombo G, Piacentini G, Uggeri F, Uggeri F. J Exp Clin Cancer Res; 2003 Jun; 22(2):179-83. PubMed ID: 12866567 [Abstract] [Full Text] [Related]
3. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers. Romano F, Uggeri F, Crippa S, Di Stefano G, Scotti M, Scaini A, Caprotti R, Uggeri F. J Exp Clin Cancer Res; 2004 Jun; 23(2):195-200. PubMed ID: 15354402 [Abstract] [Full Text] [Related]
5. IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study. Franciosi CM, Piacentini MG, Conti M, Romano F, Musco F, Caprotti R, Rovelli F, Uggeri F. Hepatogastroenterology; 2003 Jun; 50(49):297-300. PubMed ID: 12630045 [Abstract] [Full Text] [Related]
6. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients. Romano F, Cesana G, Caprotti R, Bovo G, Uggeri F, Piacentini MG, Crippa S, Uggeri F. Hepatogastroenterology; 2006 Jun; 53(70):634-8. PubMed ID: 16995478 [Abstract] [Full Text] [Related]
7. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis. Cesana GC, Romano F, Piacentini G, Scotti M, Brenna A, Bovo G, Vaghi M, Aletti G, Caprotti R, Kaufman H, Uggeri F. Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981 [Abstract] [Full Text] [Related]
8. [Radical surgical treatment of gastric cancer. Personal experience]. Meriggi F, Forni E. G Chir; 2002 Oct; 23(10):361-7. PubMed ID: 12611256 [Abstract] [Full Text] [Related]
14. Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells. Whitson BA, D'Cunha J, Hoang CD, Wu B, Ikramuddin S, Buchwald H, Panoskaltsis-Mortari A, Kratzke RA, Miller JS, Maddaus MA. Surg Obes Relat Dis; 2009 Aug; 5(2):181-93. PubMed ID: 18996756 [Abstract] [Full Text] [Related]
15. Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients. Cerea K, Romano F, Bravo AF, Motta V, Uggeri F, Brivio F, Fumagalli LA, Uggeri F. J Surg Oncol; 2001 Sep; 78(1):32-7. PubMed ID: 11519066 [Abstract] [Full Text] [Related]
16. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood? Franke A, Lante W, Kurig E, Zöller LG, Weinhold C, Markewitz A. Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447 [Abstract] [Full Text] [Related]
17. Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response? van den Engel NK, Winter H, Rüttinger D, Shau I, Schiller M, Mayer B, Moudgil T, Meimarakis G, Stolte M, Jauch KW, Fox BA, Hatz RA. Clin Immunol; 2006 Sep; 120(3):285-96. PubMed ID: 16765089 [Abstract] [Full Text] [Related]
19. Comparison of CD4 and CD8 lymphocyte counts in HIV-negative pulmonary TB patients with those in normal blood donors and the effect of antitubercular treatment: hospital-based flow cytometric study. Uppal SS, Tewari SC, Verma S, Dhot PS. Cytometry B Clin Cytom; 2004 Sep; 61(1):20-6. PubMed ID: 15351978 [Abstract] [Full Text] [Related]